🇺🇸 FDA
Patent

US 11679121

Morpholino oligonucleotides useful in cancer treatment

granted A61KA61K31/4162A61K31/711

Quick answer

US patent 11679121 (Morpholino oligonucleotides useful in cancer treatment) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4162, A61K31/711, A61K9/0019, A61P